In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Controlled Release

• Publication date

  2006-11-10

• Fields of study

  Biology, Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/J.JCONREL.2006.08.024PMID 17081643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biocompatibility evaluation of different alginates and alginate-based microcapsules.

  2005cited by this paper
• Polyelectrolytes for cell encapsulation

  2005cited by this paper
• Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules.

  2005cited by this paper
• Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.

  2005cited by this paper
• Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase‐mediated pathways

  2003cited by this paper
• Central nervous system frontiers for the use of erythropoietin.

  2003cited by this paper
• Cell microencapsulation technology for biomedical purposes: novel insights and challenges.

  2003cited by this paper
• Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery.

  2003cited by this paper
• A highly sensitive cell assay for validation of purification regimes of alginates.

  2003cited by this paper
• Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8

  2003cited by this paper
• Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts.

  2002cited by this paper
• Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates.

  2002cited by this paper
• Considerations for successful transplantation of encapsulated pancreatic islets

  2002cited by this paper
• Biocompatible alginate from freshly collected Laminaria pallida for implantation

  2000cited by this paper
• Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo

  1999cited by this paper
• Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.

  1999cited by this paper
• Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts

  1998cited by this paper
• A Gene Therapy Approach to Regulated Delivery of Erythropoietin as a Function of Oxygen Tension

  1997cited by this paper
• Biocompatibility of mannuronic acid-rich alginates.

  1997cited by this paper
• Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets

  1997cited by this paper
• Central Nervous System Delivery of Recombinant Ciliary Neurotrophic Factor by Polymer Encapsulated Differentiated C2C12 Myoblasts

  1996cited by this paper
• Recombinant human erythropoietin stimulates angiogenesis in vitro.

  1995cited by this paper
• Antigen processing and presentation by a murine myoblast cell line

  1995cited by this paper
• Erythropoietin receptor mRNA expression in human endothelial cells.

  1994cited by this paper
• NOD mouse peritoneal cellular response to poly-L-lysine-alginate microencapsulated rat islets.

  1994cited by this paper
• Lymphoid activation by different crude alginates and the effect of purification.

  1992cited by this paper
• Production of mitogen‐contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis

  1992cited by this paper
• Colorimetric assay for cellular activity in microcapsules.

  1990cited by this paper
• Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.

  1990cited by this paper
• Alginate as immobilization material. II: Determination of polyphenol contaminants by fluorescence spectroscopy, and evaluation of methods for their removal

  1989cited by this paper
• In vitro kinetics of insulin release by microencapsulated rat islets: effect of the size of the microcapsules

  1988cited by this paper
• Microencapsulated islets as bioartificial endocrine pancreas.

  1980cited by this paper
• Molecular basis for some physical properties of alginates in the gel state

  1974cited by this paper

• Microencapsulation of natural products using spray drying; an overview

  2024cites this paper
• Applications of alginate biopolymer in drug delivery

  2020cites this paper
• Update on cellular encapsulation

  2018cites this paper
• Cryopreservation of microencapsulated murine mesenchymal stem cells genetically engineered to secrete erythropoietin.

  2015cites this paper
• Stimuli-Responsive Injectable In situ-Forming Hydrogels for Regenerative Medicines

  2015cites this paper
• Advances in cell encapsulation technology and its application in drug delivery

  2015cites this paper
• Application of cell encapsulation for controlled delivery of biological therapeutics.

  2014cites this paper
• Nerve guidance channels based on PLLA–PTMC biomaterial

  2013cites this paper
• Therapeutic applications of encapsulated cells.

  2013cites this paper
• Comparison of Drug and Cell‐Based Delivery: Engineered Adult Mesenchymal Stem Cells Expressing Soluble Tumor Necrosis Factor Receptor II Prevent Arthritis in Mouse and Rat Animal Models

  2013cites this paper
• A Perspective on Bioactive Cell Microencapsulation

  2012cites this paper
• A perspective on bioactive cell microencapsulation.

  2012cites this paper
• Platelet-Rich Plasma to Improve the Bio-Functionality of Biomaterials

  2012cites this paper
• Alginate Scaffolds for Mesenchymal Stem Cell Cardiac Therapy: Influence of Alginate Composition

  2012cites this paper
• Cell microencapsulation for therapeutic purposes: towards greater control over biocompatibility

  2012cites this paper
• In Vitro and In Vivo Characterization of Nonbiomedical- and Biomedical-Grade Alginates for Articular Chondrocyte Transplantation

  2011influential citation
• Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid.

  2011cites this paper
• Emerging technologies in the delivery of erythropoietin for therapeutics

  2011cites this paper
• The Artificial Organ: Cell Encapsulation

  2011cites this paper
• Alginate-based drug delivery devices

  2010cites this paper
• Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system.

  2010cites this paper
• Novel Strategies for Neurovascular Longevity During Aging

  2010cites this paper
• Microcapsules and microcarriers for in situ cell delivery.

  2010cites this paper
• Oxidative stress: Biomarkers and novel therapeutic pathways

  2010cites this paper
• Epo delivery by genetically engineered C2C12 myoblasts immobilized in microcapsules.

  2010cites this paper
• Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells

  2010cites this paper
• A surface-eroding antibiotic delivery system based on poly-(trimethylene carbonate).

  2009cites this paper
• Low Erythropoietin Plasma Levels during Exacerbations of COPD

  2009cites this paper
• Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology

  2009cites this paper
• Gene doping: possibilities and practicalities.

  2009cites this paper
• Bioactive cell-hydrogel microcapsules for cell-based drug delivery.

  2009cites this paper
• New strategies for Alzheimer disease and cognitive impairment

  2009cites this paper
• Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression.

  2009cites this paper
• Therapy with Cell Encapsulation for Substitution of Organ Function and Tumor Treatment

  2009cites this paper
• Raves and risks for erythropoietin.

  2008cites this paper
• Tissue sites of EPO and its biological functions EPO production and expression sites Biological function Kidney Erythropoiesis Liver Protection and erythropoiesis Kupfer cells Hepatocytes Uterus Proliferation Brain Neurons

  2008cites this paper
• Erythropoietin and oxidative stress.

  2008cites this paper
• Alginate-matrigel microencapsulated Schwann cells for inducible secretion of glial cell line derived neurotrophic factor

  2008cites this paper
• Cell microencapsulation technology: towards clinical application.

  2008cites this paper
• Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.

  2008cites this paper
• Mechanistic insights into diabetes mellitus and oxidative stress.

  2007cites this paper
• Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats.

  2007cites this paper
• Alginate microparticles modified with RGD as drug delivery system.

  2007cites this paper